Amylyx Pharmaceuticals (NASDAQ:AMLX) Shares Down 2.7%

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Rating) shares were down 2.7% during mid-day trading on Friday . The company traded as low as $25.10 and last traded at $25.59. Approximately 347,433 shares traded hands during mid-day trading, a decline of 62% from the average daily volume of 904,115 shares. The stock had previously closed at […]

Related Keywords

China ,Canada ,Jamesm Frates , ,News Ratings For Amylyx Pharmaceuticals Daily ,Securities Exchange Commission ,Amylyx Pharmaceuticals Price Performance ,Goldman Sachs Group ,Amylyx Pharmaceuticals Company Profile ,Institutional Trading Of Amylyx Pharmaceuticals ,Amylyx Pharmaceuticals ,China Universal Asset Management Co ,Advisors Asset Management Inc ,Royal Bank ,Nasdaq ,Citigroup ,Amylyx Pharmaceuticals Inc ,Wells Fargo Company ,Get Rating ,Morningside Venture Investment ,Exchange Commission ,Universal Asset Management ,Asset Management ,Wells Fargo ,Amylyx Pharmaceuticals Daily ,Nasdaq Amlx ,Amlx ,Medical ,Stocks ,Technicals ,